JOSD2 and adrenal cortex carcinoma: As for JOSD2, the amplification is more frequent in a range of tumors including uterine, adrenocortical carcinoma (ACC), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), bladder, breast cancer, stomach cancer, and pancreas.